Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Randomize, Single-Blind, Trial of Liposomal Bupivacaine (EXPAREL®) for Pain Control in Post-Tonsillectomy Patients

NCT02444533 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02444533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02444533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Randomize, Single-Blind, Trial of Liposomal Bupivacaine (EXPAREL®) for Pain Control in Post-Tonsillectomy Patients
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2015
Completion date
May 31, 2016
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative pain, tonsillectomy, tonsillitis